Data availability policy

The European Chemistry and Biotechnology Journal supports transparency, reproducibility, and responsible data sharing in scientific research. Authors are encouraged to make the data underlying their findings available to readers whenever possible, while respecting ethical, legal, and privacy considerations.

Data Availability Statement

All manuscripts submitted to the journal must include a Data Availability Statement, describing:

  • Whether the data supporting the findings are publicly available;
  • Where and how the data can be accessed (e.g., repository name and persistent identifier); or
  • The reason(s) why the data cannot be shared.

Recommended Data Sharing Practices

Where appropriate, authors are encouraged to deposit research data in publicly accessible repositories relevant to their discipline (e.g., institutional repositories, subject-specific repositories, or general repositories such as Zenodo, Figshare, or Dryad).

Data shared should be:

  • Clearly described and properly documented;
  • Cited within the manuscript where relevant;
  • Linked using persistent identifiers (e.g., DOI or accession numbers).

Exceptions and Restrictions

Data sharing may be restricted when:

  • Ethical concerns apply (e.g., human participant confidentiality);
  • Legal or regulatory limitations exist;
  • Data are subject to intellectual property, commercial sensitivity, or third-party restrictions.

In such cases, authors must clearly state the reason for restricted access in the Data Availability Statement.

Data Integrity and Responsibility

Authors are responsible for ensuring that:

  • The data presented in the manuscript are accurate and have not been fabricated, falsified, or inappropriately manipulated;
  • Original data can be provided to the editorial office upon reasonable request for verification purposes.

Editorial Review and Compliance

The editorial office may review Data Availability Statements during the editorial and peer review process. Failure to provide a clear and accurate statement may delay review or publication.

If concerns regarding data integrity or availability arise after publication, the journal may take appropriate action, including issuing a correction, expression of concern, or retraction, in accordance with COPE guidelines.